β2‐adrenoceptor agonists: current and future direction
M Cazzola, L Calzetta… - British journal of …, 2011 - Wiley Online Library
Despite the passionate debate over the use of β2‐adrenoceptor agonists in the treatment of
airway disorders, these agents are still central in the symptomatic management of asthma …
airway disorders, these agents are still central in the symptomatic management of asthma …
[引用][C] β2-adrenoceptor agonists: current and future direction
M CAZZOLA, L CALZETTA… - British journal of …, 2011 - pascal-francis.inist.fr
β2-adrenoceptor agonists: current and future direction CNRS Inist Pascal-Francis CNRS
Pascal and Francis Bibliographic Databases Simple search Advanced search Search by …
Pascal and Francis Bibliographic Databases Simple search Advanced search Search by …
β (2)-adrenoceptor agonists: current and future direction.
M Cazzola, L Calzetta, MG Matera - British Journal of Pharmacology, 2011 - europepmc.org
Despite the passionate debate over the use of β 2-adrenoceptor agonists in the treatment of
airway disorders, these agents are still central in the symptomatic management of asthma …
airway disorders, these agents are still central in the symptomatic management of asthma …
[引用][C] beta (2)-adrenoceptor agonists: current and future direction
M Cazzola, L Calzetta, M Matera - BRITISH JOURNAL OF …, 2011 - air.unipr.it
beta(2)-adrenoceptor agonists: current and future direction IRIS IRIS Home Sfoglia
Macrotipologie & tipologie Autore Titolo Riviste Serie IT Italiano Italiano English English …
Macrotipologie & tipologie Autore Titolo Riviste Serie IT Italiano Italiano English English …
β2‐adrenoceptor agonists: current and future direction
M Cazzola, L Calzetta, MG Matera - British Journal of Pharmacology, 2011 - cir.nii.ac.jp
抄録< jats: p> Despite the passionate debate over the use of β< jats: sub> 2</jats: sub>‐
adrenoceptor agonists in the treatment of airway disorders, these agents are still central in …
adrenoceptor agonists in the treatment of airway disorders, these agents are still central in …
β (2)-adrenoceptor agonists: current and future direction
M Cazzola, L Calzetta… - British journal of …, 2011 - pubmed.ncbi.nlm.nih.gov
Despite the passionate debate over the use of β (2)-adrenoceptor agonists in the treatment
of airway disorders, these agents are still central in the symptomatic management of asthma …
of airway disorders, these agents are still central in the symptomatic management of asthma …
[HTML][HTML] β2-adrenoceptor agonists: current and future direction
M Cazzola, L Calzetta, MG Matera - British Journal of …, 2011 - ncbi.nlm.nih.gov
Despite the passionate debate over the use of β 2-adrenoceptor agonists in the treatment of
airway disorders, these agents are still central in the symptomatic management of asthma …
airway disorders, these agents are still central in the symptomatic management of asthma …
[引用][C] β (2)-adrenoceptor agonists: current and future direction
M Cazzola, L Calzetta, MG Matera - BRITISH JOURNAL OF …, 2011 - iris.unicampania.it
β (2)-adrenoceptor agonists: current and future direction
M Cazzola, L Calzetta, M Matera - BRITISH JOURNAL OF …, 2011 - art.torvergata.it
Despite the passionate debate over the use of β (2)-adrenoceptor agonists in the treatment
of airway disorders, these agents are still central in the symptomatic management of asthma …
of airway disorders, these agents are still central in the symptomatic management of asthma …